PAVmed (PAVM) Capital Expenditures Growth (3y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.08% |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | -63.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -63.92% |
| Sep 30, 2025 | -78.83% |
| Jun 30, 2025 | -71.67% |
| Mar 31, 2025 | -78.14% |
| Dec 31, 2024 | -85.37% |
| Jun 30, 2024 | -70.84% |
| Mar 31, 2024 | 5.27% |
| Dec 31, 2023 | 183.87% |
| Sep 30, 2023 | 81.71% |
| Jun 30, 2023 | -29.05% |
| Mar 31, 2023 | 135.13% |
| Dec 31, 2022 | 430.15% |
| Jun 30, 2022 | 151.98% |
| Mar 31, 2022 | 476.23% |
| Dec 31, 2021 | 640.50% |
| Mar 31, 2020 | -27.74% |
| Jun 30, 2019 | 125.64% |
| Mar 31, 2019 | -37.90% |